» Articles » PMID: 28112068

Coeliac Disease and Invasive Pneumococcal Disease: a Population-based Cohort Study

Overview
Date 2017 Jan 24
PMID 28112068
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Severe infections are recognized complications of coeliac disease (CD). In the present study we aimed to examine whether individuals with CD are at increased risk of invasive pneumococcal disease (IPD). To do so, we performed a population-based cohort study including 29 012 individuals with biopsy-proven CD identified through biopsy reports from all pathology departments in Sweden. Each individual with CD was matched with up to five controls (n = 144 257). IPD events were identified through regional and national microbiological databases, including the National Surveillance System for Infectious Diseases. We used Cox regression analyses to estimate hazard ratios (HRs) for diagnosed IPD. A total of 207 individuals had a record of IPD whereas 45/29 012 had CD (0·15%) and 162/144 257 were controls (0·11%). This corresponded to a 46% increased risk for IPD [HR 1·46, 95% confidence interval (CI) 1·05-2·03]. The risk estimate was similar after adjustment for socioeconomic status, educational level and comorbidities, but then failed to attain statistical significance (adjusted HR 1·40, 95% CI 0·99-1·97). Nonetheless, our study shows a trend towards an increased risk for IPD in CD patients. The findings support results seen in earlier research and taking that into consideration individuals with CD may be considered for pneumococcal vaccination.

Citing Articles

Vaccine Efficacy and Safety in Patients with Celiac Disease.

Scarmozzino R, Zanoni G, Arcolaci A, Ciccocioppo R Vaccines (Basel). 2025; 12(12.

PMID: 39771990 PMC: 11679483. DOI: 10.3390/vaccines12121328.


Contribution of Infectious Agents to the Development of Celiac Disease.

Sanchez D, Hoffmanova I, Szczepankova A, Habova V, Tlaskalova-Hogenova H Microorganisms. 2021; 9(3).

PMID: 33800833 PMC: 8001938. DOI: 10.3390/microorganisms9030547.


Risk of Severe Covid-19 in Patients with Celiac Disease: A Population-Based Cohort Study.

Lebwohl B, Larsson E, Soderling J, Roelstraete B, Murray J, Green P Clin Epidemiol. 2021; 13:121-130.

PMID: 33628059 PMC: 7899312. DOI: 10.2147/CLEP.S294391.


Celiac disease and complement activation in response to Streptococcus pneumoniae.

Rockert Tjernberg A, Woksepp H, Sandholm K, Johansson M, Dahle C, Ludvigsson J Eur J Pediatr. 2019; 179(1):133-140.

PMID: 31691001 PMC: 6942560. DOI: 10.1007/s00431-019-03490-w.


The use of an invitational letter to increase the vaccine uptake of patients with coeliac disease.

Moneim J, Asad H, Butt E, Foridi J, Khan Y, Patel S Prim Health Care Res Dev. 2019; 20:e142.

PMID: 31663488 PMC: 6842643. DOI: 10.1017/S1463423619000781.


References
1.
Inghammar M, Engstrom G, Kahlmeter G, Ljungberg B, Lofdahl C, Egesten A . Invasive pneumococcal disease in patients with an underlying pulmonary disorder. Clin Microbiol Infect. 2013; 19(12):1148-54. DOI: 10.1111/1469-0691.12182. View

2.
Ludvigsson J, Brandt L, Montgomery S, Granath F, Ekbom A . Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol. 2009; 9:19. PMC: 2664822. DOI: 10.1186/1471-230X-9-19. View

3.
Muller A, Toghill P . Hyposplenism in gastrointestinal disease. Gut. 1995; 36(2):165-7. PMC: 1382396. DOI: 10.1136/gut.36.2.165. View

4.
Elfstrom P, Sundstrom J, Ludvigsson J . Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther. 2014; 40(10):1123-32. DOI: 10.1111/apt.12973. View

5.
Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjostrom K . Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J. 2016; 47(4):1208-18. PMC: 4819883. DOI: 10.1183/13993003.01451-2015. View